CD81

CD81

a type III transmembrane protein present on many cell types, including lymphocytes, which facilitates signal transduction; expressed on lymphomas, leukemias, melanomas, and neuroblastomas.
Mentioned in ?
References in periodicals archive ?
This is supported by experiments showing that hepatic CD81 expression is increased in Pcsk9 (KO) mice and PCSK9 downregulates CD81 independently of LDL-R.
Are there differences between laboratories that use of fail to use the CDC's guidelines to measure CD41 and CD81 T cells?
Expression of CD21 forms a complex with CD19 and CD81 to form the B cell coreceptor and it can serve as antigen-presenting cells, secrete cytokines, and differentiate into plasma cells that produce and secrete immunoglobulins (Foote et al.
Newer markers, such as CD81, may also prove helpful in this distinction.
Summary: TEHRAN (FNA)- Researchers found that mutations in the CD81 gene are the genetic cause of antibody deficiency.
CD81 along with human scavenger receptor SR-BI, and tight junction molecules claudin-1 (CLDN) and occludin (OCLN) are the most important receptors that mediate HCV entry (46).
B lenfositlerinin yuzeyinde B hucre almaci (reseptoru) ile birlikte CD19, CD21, CD81 ve CD225 gibi ko-reseptorler de bulunmaktadir (13).
CD19 molekulu CD21, CD81 ve CD225 ile B hucre reseptor kompleksi olusturarak antijen baglanmasi sonrasi B hucre reseptor sinyallerini kuvvetlendirir.
It is now felt that HCV antigens bind to CD81, leading to B-cell specific multimolecular signaling.
After the naive mature B lymphocyte contacts the immunogen through surface IgM and/or IgD [with or without the B-lymphocyte CD21 (CR2), CD19, CD81 coreceptor interaction], help must be supplied by T-helper 1 or 2 cells to class switch to IgG (affinity maturation takes place as well).
Schwartz et al (20) demonstrated high levels of the neural stem cell markers like CD133, CD44, CD81, CD184, CD90, and CD29 positive but CD133 cell population was decreased in high-passage, lineage-restricted cultures.
Patent applications currently pending before the US Patent and Trademark Office are directed to genes of lipoprotein-associated phospholipase A2, Snare YKT6, glucokinase, adipocyte enhancer binding protein, POLD2 polymerase, SMS3, Phemx (TSSC6), TSSC4, HASH2, ribosomal protein L26, MDM2, carboxypeptidase D, carboxypeptidase M, RhoC, soluble aminopeptidase P and CD81 antigen.